|
HS Code |
817613 |
As an accredited 6-Bromo-3H-Isobenzofuran-1-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-3H-Isobenzofuran-1-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone who has spent any time working in organic synthesis knows how certain building blocks can make or break the success of a project. 6-Bromo-3H-Isobenzofuran-1-One stands out for good reason. It’s not just another fine chemical tossed into the endless product catalog. This compound, with its brominated lactone structure, has earned its place in medicinal chemistry and specialty materials research labs. There’s a lot more going on than just the quirks of its aromatic ring and the reactive potential of that bromine atom—so let's dig into why researchers have gravitated toward it, how it fits into the workflow, and what makes it different from a sea of similar-looking molecules.
No chemist forgets those nights spent puzzling over synthetic routes, looking for efficiency where none seems to exist. For folks running benchtop reactions in university or R&D settings, 6-Bromo-3H-Isobenzofuran-1-One slides onto the experimental sheet simply because it manages to serve as a flexible branching point. This molecule, defined by a compact phthalide core substituted at the six position, tends to be a reliable way to create more elaborately designed compounds—whether heading toward heterocycles, building larger aromatic systems, or grafting new side chains.
Its structure matters. The bromine atom sits at the sixth carbon, lending a distinct character to its reactivity. In cross-coupling reactions, the bromide often acts as a handle. Many researchers, myself included, have leveraged this detail to design Suzuki or Buchwald–Hartwig couplings without lengthy protection–deprotection steps. There isn't one path forward, either: whether it's installing electron-rich motifs or introducing new pharmacophores, having that simple bromine there, instead of chlorine or fluorine, really changes the scope of what's possible.
Digging through the academic literature from the past 25 years reveals a recurring trend: the phthalide skeleton, especially halogenated versions, Feature in a number of synthetic journeys. Medicinal chemists love this scaffold for its promise in anti-cancer and anti-inflammatory studies. Having a bromine, as in 6-Bromo-3H-Isobenzofuran-1-One, opens doors for subsequent functionalizations that aren't as easy to access with methyl, nitro, or simpler hydroxy substitutions.
I recall a discussion in a group meeting about fragment-based drug discovery. A spectroscopist was convinced that adding bulk and electronics to certain scaffolds would flip the binding affinity. Sure enough, the introduction of brominated phthalides upped polarity and tuneability. People in industry vouch for this versatility—not every compound in the screening library lands on a clinical development track, but those with accessible bromine substituents often find themselves ‘rescued’ for another round because new reactions are straightforward.
In fine chemical production, access to bromo intermediates has streamlined a range of synthesis tasks. This compound finds its way into asymmetric synthesis, total synthesis of natural products, and the chase for novel materials, like organic semiconductors and photoinitiators. That’s a broad reach for a single molecule—a testament to why chemists keep asking for it by name instead of just opting for more generic alternatives.
Purity, and I speak from my own practical regrets here, doesn’t just mean a pretty certificate of analysis. It makes or breaks reproducibility. The real headaches come from running reactions with a starting material that’s even slightly off the stated spec. 6-Bromo-3H-Isobenzofuran-1-One rarely poses these headaches when sourced from a supplier with a reputation for quality-assured lots. The difference becomes clear in chromatography: faint streaks on TLC plates from minor impurities, or inconsistent yields despite flawless reaction planning, all point to problems upstream.
Because phthalide systems tend to tautomerize or hydrolyze in some conditions, I always double-check for dryness and storage. For researchers under grant deadlines, losing weeks due to botched intermediates is more than an academic inconvenience. Reliable sources offer material as a crystalline solid, often in pale to beige tones, melting around the mid double digits Celsius, with NMR and LC/MS characterization provided on request. For anyone curious about what makes or derails a complex project: this is where personal experience sides with data sheets over marketing gloss.
Plenty of halogenated lactones crowd the reagent shelf. What makes 6-Bromo-3H-Isobenzofuran-1-One step forward? It’s not just a question of halide swaps. Bromine strikes a balance between reactivity and stability—easier to couple or substitute than iodine, but less prone to environmental or human health concerns than some heavier halides, and less recalcitrant than chlorine in most standard cross-coupling chemistry.
If, like me, you’ve spent weekends puzzling over why one batch runs fine while another fizzles out, shelf life and susceptibility to air or moisture matter, too. The phthalide unit brings cyclic stability, so this isn’t a material that turns oily after a few days out of the fridge. Compounds substituted with nitro or methyl might headline in older, less adaptable syntheses, but brominated analogs survive regulatory scrutiny more easily and offer broader downstream functionalization.
It’s fair to admit the alternatives—6-chloro, for example—carry some advantages in cost, but they don’t have the same scope for late-stage diversification. Fluorinated systems attract interest from those chasing PET imaging probes or metabolically stable drug candidates, but introducing a fluorine at the six position can force reaction conditions into harsher territory. 6-Bromo-3H-Isobenzofuran-1-One, in contrast, keeps its reactivity accessible, which is exactly what’s needed when you want options open further down the synthesis path.
For bench chemists, applying this compound rarely stays theoretical. I’ve teamed with medicinal chemists and process development scientists who keep returning to this building block when scaling up an interesting lead. Suzuki couplings using this bromo-compound routinely outperform their chloro cousins on both yield and cost per gram, especially once you get beyond the milligram scale.
In my experience, who you work with shapes your approach. One collaboration focused on synthesizing new benzofused heterocycles for kinase inhibitor screening. The group’s postdocs tried both commercial and in-house prepped batches—with the reputable material, side reactions fell away, cleanup became easier, and timelines actually matched what was on the Gantt chart for once.
For anyone curious about what gets shared across research group boundaries, brominated lactones like this one keep popping up in conference talks and published protocols as handy intermediates for all sorts of functionalizations: alkylations at carbon 3, nucleophilic substitutions at carbon 6, complex annulations leading to polycycles, and domino sequences that lock in multiple new bonds in a single pot. The stories come from medicine, materials science, and even flavor and fragrance R&D.
Commercially, genuine 6-Bromo-3H-Isobenzofuran-1-One matches the formula C8H5BrO2 and weighs in around 213.03 g/mol. From a practical point of view, that translates to a scalable, reliable molecule that dissolves in common organic solvents—dichloromethane, ethyl acetate, and acetonitrile among them. Most batches ship as crystalline or microcrystalline powder, with melting points typically cited in the 80–84 °C range.
I’ve measured hygroscopicity over weeks in an uncontrolled lab and rarely noticed caking or discoloration. Still, any moisture cuts down shelf life, especially if you want to use it months down the road. Most labs bag and bottle it under inert blanket, sticking with glass containers. That’s standard good practice across the board, as is verifying identity with proton NMR and checking purity via HPLC or LC/MS.
Some vendors push extra purity levels, up to 99%, but in practical synthesis runs, material above 97% usually meets the requirements. The most pressing difference isn’t the absolute spec but the batch consistency—good lots don’t vary much from bottle to bottle. I’ve swapped tips with colleagues picking between batches, learning that a supplier’s track record means more than any claimed stat. It’s common sense born from repeated frustration: odd peaks or yields rarely come from the scheme on paper, but from the bottle on the shelf.
There are plenty of tools in the chemist’s toolbox. What sets some apart boils down to reliability, adaptability, and accessibility. 6-Bromo-3H-Isobenzofuran-1-One checks boxes in every direction—compatible with a broad swath of reactions, able to take on modifications at the bench, relatively affordable compared to fancier fluorinated cousins. This has ripple effects on innovation, especially for academic teams on tight budgets and industrial groups where time equals money.
Start-up ventures tackling targets in oncology or anti-infectives have moved faster by integrating flexible building blocks like this one into their hit-to-lead workflow. Too many times, bottlenecks in chemical supply cause promising ideas to stall. The speed and reliability of synthesis feed directly into the ability to iterate, test, and refine ideas in a timely way. I’ve seen once-stalled targeting campaigns lurch forward when a core intermediate can be switched out on the fly for bromo-analogues, allowing chemists to explore new vectors of SAR (structure-activity relationships) without revising the entire synthetic route.
In materials chemistry, too, a flexible intermediate enables winning strategies. Organic electronics are a growing field, and chemists racing to improve the performance of molecular semiconductors often reach for functionalized phthalides. The brominated version adapts to state-of-the-art cross-coupling and polymerization protocols. I've followed project teams developing new OLED emitters who rely on halogenated lactones to tune energy levels and electronic properties. A common refrain among my old lab mates: access to clean bromo-lactones shaved months off screening cycles, letting the real breakthroughs happen at the device-testing stage instead of the flask.
No tool is perfect. Some challenges with 6-Bromo-3H-Isobenzofuran-1-One revolve around sourcing, logistics, and environmental policies. Occasionally, regulatory shifts around hazardous chemicals have made sourcing certain halogenated building blocks tricky. Environmental, Health, and Safety (EHS) considerations extend to brominated organics, especially at greater than research scale, requiring proper waste handling and disposal pathways.
Teams working under stricter regulatory jurisdictions face shipping delays, additional paperwork, and sometime supply chain interruptions. This highlights an urgent need for transparent, responsible sourcing, along with clear, reliable documentation. I’ve worked with procurement teams who learned the hard way that cheapest isn’t always best—reputable suppliers keep both paperwork and the product itself in line with relevant industry expectations, from hazard labeling to batch traceability.
Sustainability is gaining ground. A few manufacturers have begun exploring greener synthesis pathways—using recyclable solvents, milder reagents, and lower-energy conditions. In a recent green chemistry workshop, process chemists outlined successes with aqueous-phase functionalization and continuous flow reactors for halogen exchange and lactonization. These approaches offer decent yields and cut down on toxic byproducts. Academic–industrial partnerships have started to bridge innovation gaps, especially in terms of lifecycle thinking for specialty building blocks.
As regulations grow tighter and pressure for non-toxic processes increases, some companies are developing new variants or upgrading plant facilities to comply with modern safety standards. It’s not just a trend: responsible chemical management safeguards both workers and the local environment near production sites. I've participated in audits where supply chain transparency and documentation of compliance mark the difference between a long-term supply relationship and short-term delays.
Chemistry continually evolves, often faster than outside observers realize. That’s partly why a compound like 6-Bromo-3H-Isobenzofuran-1-One keeps its value. Its compatibility with both legacy and cutting-edge synthetic tools lays the groundwork for quick pivots to new scientific priorities—be it in small-molecule drugs, fine materials, or even greener process development. The conversational culture in chemistry, thriving across academic–industry boundaries, has ensured that best practices and creative routes get shared and refined at conferences, in papers, and through informal networks.
In my own consulting work, I’ve watched research teams iterate between analogues, often jumping from early candidates straight to bromo-phthalides to open more doors downstream. The pace of drug discovery makes every modular step count. Organizations with nimble procurement and on-demand synthesis teams can react to new data without redrafting every synthetic plan from scratch. The best choices signal readiness for whatever direction the project takes.
In the end, the argument for considering 6-Bromo-3H-Isobenzofuran-1-One in synthesis work comes straight from the day-to-day struggles and small wins at the bench. The ease with which it plugs into well-known transformations—Suzuki, Heck, or Buchwald–Hartwig couplings—makes it a friend to those juggling multiple projects. Reliable access, good documentation, and decent shelf stability shape its long-term usability.
As more chemists look for modular, safe, and versatile building blocks—especially in the face of stricter EHS regulations and tightening research funding—this bromo-phthalide will likely stay a preferred choice. My own journey, and the stories of scores of colleagues, attest to the day-saving magic of having reliable intermediates on hand. Each time a reaction run matches the one on paper, there’s a quiet sigh of relief. That reliability, earned in real labs by real people, means more for the future of innovation than any marketing pitch or chemical catalog can convey.